Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$41.00
-11.77%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$131.33
Range $104.00 – $150.00
Implied Upside
+220.3%
Consensus $131.33 vs current $41.00